↓ Skip to main content

Dabigatran: how the drug company withheld important analyses

Overview of attention for article published in British Medical Journal, July 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
9 news outlets
blogs
6 blogs
policy
2 policy sources
twitter
678 tweeters
peer_reviews
1 peer review site
facebook
29 Facebook pages
wikipedia
1 Wikipedia page
googleplus
3 Google+ users
reddit
1 Redditor
video
1 video uploader

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
127 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dabigatran: how the drug company withheld important analyses
Published in
British Medical Journal, July 2014
DOI 10.1136/bmj.g4670
Pubmed ID
Authors

D. Cohen

Twitter Demographics

The data shown below were collected from the profiles of 678 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
Spain 2 2%
Denmark 2 2%
Brazil 1 <1%
Italy 1 <1%
Egypt 1 <1%
United States 1 <1%
Austria 1 <1%
Unknown 115 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 22%
Other 18 14%
Professor > Associate Professor 15 12%
Student > Bachelor 14 11%
Student > Master 13 10%
Other 39 31%
Readers by discipline Count As %
Medicine and Dentistry 92 72%
Unspecified 11 9%
Agricultural and Biological Sciences 10 8%
Business, Management and Accounting 3 2%
Design 2 2%
Other 9 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 582. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2019.
All research outputs
#10,563
of 12,689,901 outputs
Outputs from British Medical Journal
#259
of 42,240 outputs
Outputs of similar age
#150
of 192,176 outputs
Outputs of similar age from British Medical Journal
#3
of 568 outputs
Altmetric has tracked 12,689,901 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,240 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 568 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.